The FDA Oncologic Drugs Advisory Committee, in an 13-4 vote, recommended against approval of retifanlimab, a PD-1 inhibitor, for the treatment of squamous carcinoma of the anal canal.
The NCI Board of Scientific Advisors approved four new concepts, which includes Requests for Applications, Cooperative Agreements, and Program Announcements.
An NCI press conference is rarely a tabloid affair—except on Sept. 30, 1974. What was anticipated to be a dry occasion shifted when Betty Ford, wife of President Gerald Ford, underwent a radical mastectomy Sept. 28.
True, President Joe Biden is proposing the largest-ever funding increase for NIH, with a substantial percentage of funds going toward cancer.
The Advanced Research Projects Agency for Health, the centerpiece of the Biden Administration’s war on disease, is designed to be something much more than an ordinary federal bureaucracy.
In March 2010, as part of Affordable Care Act, Congress passed a well-conceived and critical legislative bill, the Biologic Pricing and Competition Innovation Act of 2009 (BPCIA)
Alan Rabson and Ruth Kirschstein came to NIH together and became a graceful power couple. Kirschstein would become a key contributor to the development of a safe and effective polio vaccine and the first woman director of a major institute at the NIH.
The Cancer Letter received eight 2021 Dateline Awards from the Washington, D.C. Chapter of the Society of Professional Journalists—five for journalism, and three for illustration.
In the days leading up to the 2021 American Society of Clinical Oncology annual meeting, The Cancer Letter published a piece focused on Axel Grothey’s unethical sexual relationships with women he mentored while at Mayo Clinic. While this news was met by some as shocking, science tells us it is anything but.
It took Narjust Duma a long time to feel like she belonged in medicine in the U.S. Here is her story.
